長期投資家のためのIR情報
 バリュートレンド
  1. HOME
  2. バリュートレンド
  3. 【3386】コスモ・バイオ

【3386】コスモ・バイオ
研究用試薬などの商社。
類似企業：


東証スタンダード
卸売
＞
医卸
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)		 対前回 修正率 修正率 営業利益
(百万円)		 対前回 修正率 修正率 経常利益
(百万円)		 対前回 修正率 修正率 当期利益
(百万円)		 対前回 修正率 修正率
2024.12 2024/11/07 Q3予 9,800 → 0.0% 0.0% 390 → 0.0% 0.0% 450 → 0.0% 0.0% 310 → 0.0% 0.0%
2024.12 2024/08/05 Q2予 9,800 → 0.0% 0.0% 390 → 0.0% 0.0% 450 → 0.0% 0.0% 310 → 0.0% 0.0%
2024.12 2024/05/09 Q1予 9,800 → 0.0% 0.0% 390 → 0.0% 0.0% 450 → 0.0% 0.0% 310 → 0.0% 0.0%
2024.12 2024/02/14 当初予 9,800 - - - 390 - - - 450 - - - 310 - - -
2023.12 2024/02/14 実 9,340 ↓ -4.7% -4.7% 519 ↓ -13.5% -13.5% 653 ↓ -1.1% -1.1% 442 ↓ -1.8% -1.8%
2023.12 2023/11/07 Q3予 9,800 → 0.0% 0.0% 600 → 0.0% 0.0% 660 → 0.0% 0.0% 450 → 0.0% 0.0%
2023.12 2023/08/04 Q2予 9,800 → 0.0% 0.0% 600 → 0.0% 0.0% 660 → 0.0% 0.0% 450 → 0.0% 0.0%
2023.12 2023/05/10 Q1予 9,800 → 0.0% 0.0% 600 → 0.0% 0.0% 660 → 0.0% 0.0% 450 → 0.0% 0.0%
2023.12 2023/02/14 当初予 9,800 - - - 600 - - - 660 - - - 450 - - -
2022.12 2023/02/14 実 9,553 ↓ -0.5% +1.6% 816 ↑ +16.6% -1.7% 790 ↑ +11.3% -9.2% 517 ↑ +10.0% -10.9%
2022.12 2022/11/07 Q3予 9,600 → 0.0% +2.1% 700 → 0.0% -15.7% 710 → 0.0% -18.4% 470 → 0.0% -19.0%
2022.12 2022/08/04 Q2予 9,600 → 0.0% +2.1% 700 → 0.0% -15.7% 710 → 0.0% -18.4% 470 → 0.0% -19.0%
2022.12 2022/07/25 修正予 9,600 ↑ +2.1% +2.1% 700 ↓ -15.7% -15.7% 710 ↓ -18.4% -18.4% 470 ↓ -19.0% -19.0%
2022.12 2022/05/10 Q1予 9,400 → 0.0% 0.0% 830 → 0.0% 0.0% 870 → 0.0% 0.0% 580 → 0.0% 0.0%
2022.12 2022/02/14 当初予 9,400 - - - 830 - - - 870 - - - 580 - - -
2021.12 2022/02/14 実 9,231 ↑ +2.6% +12.6% 1,048 ↑ +16.4% +49.7% 1,099 ↑ +15.7% +46.5% 737 ↑ +17.0% +53.5%
2021.12 2021/11/05 Q3予 9,000 → 0.0% +9.8% 900 → 0.0% +28.6% 950 → 0.0% +26.7% 630 → 0.0% +31.3%
2021.12 2021/08/05 Q2予 9,000 ↑ +9.8% +9.8% 900 ↑ +28.6% +28.6% 950 ↑ +26.7% +26.7% 630 ↑ +31.3% +31.3%
2021.12 2021/05/10 Q1予 8,200 → 0.0% 0.0% 700 → 0.0% 0.0% 750 → 0.0% 0.0% 480 → 0.0% 0.0%
2021.12 2021/02/12 当初予 8,200 - - - 700 - - - 750 - - - 480 - - -
2020.12 2021/02/12 実 8,092 ↑ +3.7% +4.4% 752 ↑ +27.5% +74.9% 817 ↑ +23.8% +66.7% 674 ↑ +24.8% +117.4%
2020.12 2020/11/06 Q3予 7,800 → 0.0% +0.6% 590 → 0.0% +37.2% 660 → 0.0% +34.7% 540 → 0.0% +74.2%
2020.12 2020/08/05 Q2予 7,800 → 0.0% +0.6% 590 → 0.0% +37.2% 660 → 0.0% +34.7% 540 → 0.0% +74.2%
2020.12 2020/07/21 修正予 7,800 ↑ +0.6% +0.6% 590 ↑ +37.2% +37.2% 660 ↑ +34.7% +34.7% 540 ↑ +74.2% +74.2%
2020.12 2020/05/11 Q1予 7,750 → 0.0% 0.0% 430 → 0.0% 0.0% 490 → 0.0% 0.0% 310 → 0.0% 0.0%
2020.12 2020/02/14 当初予 7,750 - - - 430 - - - 490 - - - 310 - - -
2019.12 2020/02/14 実 7,590 ↑ +2.6% +2.6% 405 ↑ +15.7% +102.5% 470 ↑ +22.1% +88.0% 237 ↓ -5.2% +69.3%
2019.12 2019/11/06 Q3予 7,400 → 0.0% 0.0% 350 → 0.0% +75.0% 385 → 0.0% +54.0% 250 → 0.0% +78.6%
2019.12 2019/08/05 Q2予 7,400 → 0.0% 0.0% 350 → 0.0% +75.0% 385 → 0.0% +54.0% 250 → 0.0% +78.6%
2019.12 2019/07/23 修正予 7,400 → 0.0% 0.0% 350 ↑ +75.0% +75.0% 385 ↑ +54.0% +54.0% 250 ↑ +78.6% +78.6%
2019.12 2019/05/10 Q1予 7,400 → 0.0% 0.0% 200 → 0.0% 0.0% 250 → 0.0% 0.0% 140 → 0.0% 0.0%
2019.12 2019/02/14 当初予 7,400 - - - 200 - - - 250 - - - 140 - - -
2018.12 2019/02/14 実 7,261 → 0.0% -3.2% 328 ↑ +0.6% +68.2% 403 ↑ +0.2% +64.5% 260 ↑ +0.4% +73.3%
2018.12 2019/01/31 修正予 7,261 ↓ -3.2% -3.2% 326 ↑ +67.2% +67.2% 402 ↑ +64.1% +64.1% 259 ↑ +72.7% +72.7%
2018.12 2018/11/05 Q3予 7,500 → 0.0% 0.0% 195 → 0.0% 0.0% 245 → 0.0% 0.0% 150 → 0.0% 0.0%
2018.12 2018/08/03 Q2予 7,500 - - - 195 - - - 245 - - - 150 - - -
2017.12 2018/02/14 修正予 7,068 ↓ -1.8% -5.8% 193 ↑ +37.9% +67.8% 397 ↑ +10.3% +120.6% 237 ↑ +3.0% +125.7%
2017.12 2017/11/06 Q3予 7,200 → 0.0% -4.0% 140 → 0.0% +21.7% 360 → 0.0% +100.0% 230 → 0.0% +119.0%
2017.12 2017/08/04 修正予 7,200 ↓ -4.0% -4.0% 140 ↑ +21.7% +21.7% 360 ↑ +100.0% +100.0% 230 ↑ +119.0% +119.0%
2017.12 2017/05/09 Q1予 7,500 → 0.0% 0.0% 115 → 0.0% 0.0% 180 → 0.0% 0.0% 105 → 0.0% 0.0%
2017.12 2017/02/14 当初予 7,500 - - - 115 - - - 180 - - - 105 - - -
2016.12 2017/02/14 実 7,427 ↓ -2.3% -4.2% 514 ↑ +28.5% +328.3% 483 ↑ +27.1% +119.5% 254 ↑ +5.8% +111.7%
2016.12 2016/11/07 Q3予 7,600 → 0.0% -1.9% 400 → 0.0% +233.3% 380 → 0.0% +72.7% 240 → 0.0% +100.0%
2016.12 2016/08/05 修正予 7,600 ↓ -1.9% -1.9% 400 ↑ +233.3% +233.3% 380 ↑ +72.7% +72.7% 240 ↑ +100.0% +100.0%
2016.12 2016/02/12 当初予 7,750 - - - 120 - - - 220 - - - 120 - - -
2015.12 2016/02/12 実 7,357 → 0.0% -5.2% 200 → 0.0% +185.7% 373 → 0.0% +86.5% 230 ↓ -0.4% +91.7%
2015.12 2016/01/27 修正予 7,357 ↓ -5.2% -5.2% 200 ↑ +122.2% +185.7% 373 ↑ +38.1% +86.5% 231 ↑ +44.4% +92.5%
2015.12 2015/11/09 Q3予 7,760 → 0.0% 0.0% 90 → 0.0% +28.6% 270 → 0.0% +35.0% 160 → 0.0% +33.3%
2015.12 2015/08/10 修正予 7,760 → 0.0% 0.0% 90 ↑ +28.6% +28.6% 270 ↑ +35.0% +35.0% 160 ↑ +33.3% +33.3%
2015.12 2015/05/08 Q1予 7,760 - - - 70 - - - 200 - - - 120 - - -
2014.12 2014/11/06 Q3予 7,300 → 0.0% 0.0% 260 → 0.0% +0.8% 410 → 0.0% +4.1% 265 → 0.0% +13.7%
2014.12 2014/08/07 修正予 7,300 → 0.0% 0.0% 260 ↑ +0.8% +0.8% 410 ↑ +4.1% +4.1% 265 ↑ +13.7% +13.7%
2014.12 2014/05/08 Q1予 7,300 → 0.0% 0.0% 258 → 0.0% 0.0% 394 → 0.0% 0.0% 233 → 0.0% 0.0%
2014.12 2014/02/14 当初予 7,300 - - - 258 - - - 394 - - - 233 - - -
2013.12 2014/02/14 実 7,050 - - - 271 - - - 444 - - - 313 - - -
シェア ツイート
ページトップへ戻る